PLAB Q1 2026 Earnings EPS Beat Drives Stock Higher CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development UHAL Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises Despite Loss TD Q1 2026 Earnings EPS Beat Bolsters Investor Confidence Amidst Ongoing Regulatory Challenges CLPT Q1 2026 Earnings EPS Misses Estimates as ClearPoint Neuro Continues Strategic Investments VABK Q1 2026 Earnings EPS of 097 Highlights Steady Performance Amid Limited Disclosure